Skip to content

Effectiveness and cost-effectiveness of internet-based treatment for insomnia in depressed patients treated at a mental healthcare outpatient clinic.

Effectiveness and cost-effectiveness of internet-based treatment for insomnia in depressed patients treated at a mental healthcare outpatient clinic. - EINSTEIN

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON50166
Enrollment
175
Registered
2020-09-04
Start date
2020-11-12
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depressieve stemmingstoornis depression insomnia mood disorder sleeping problems

Interventions

i-Sleep is a guided, internet-based cognitive behavioural therapy for insomnia, which will be added to usual care for depression in specialized mental healthcare. The i-Sleep program consists of 5 o

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • 18 years or older with a maximum age of 75 years, • Scheduled for treatment of unipolar depression according to the DSM-5 criteria at one of the abovementioned specialized mental healthcare outpatient clinics, • Fulfilling the DSM-5 criteria for insomnia disorder.

Exclusion criteria

Exclusion criteria: • Insufficient command of the Dutch language, • Working night shifts, • Sleep-related conditions other than insomnia, e.g. sleep apnoea, • No daily access to an internet-connected computer, • Presence of a mental health crisis situation.

Design outcomes

Primary

MeasureTime frame
The main study parameter is the change in depressive symptoms within patients at 3, 6, 9 and 12 months of follow-up, as well as the difference between intervention and control groups. This will be assessed with the Patient Health Questionnaire-9 (PHQ-9).

Secondary

MeasureTime frame
Secondary outcomes are insomnia severity (Insomnia Severity Index, ISI), daily functioning (Work and Social Adjustment Scale, WSAS), general quality of life (EuroQol 5-level version, EQ-5D-5L), lost productivity costs (adapted version of the iMTA Productivity Cost Questionnaire, iPCQ) and healthcare, patient and family costs (adapted version of the iMTA Medical Cost Questionnaire, iMCQ).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)